FDA Drug Application (204119) for EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE by HETERO DRUGS LTD

Back to FDA Applications sponsored by HETERO DRUGS LTD

Application Number204119
Product Number001
FormTABLET; ORAL
Dosage600MG;300MG;300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
Active IngredientEFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by HETERO DRUGS LTD